Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

BUY
$8.22 - $13.81 $86,310 - $145,005
10,500 New
10,500 $106,000
Q4 2022

Feb 14, 2023

BUY
$8.74 - $16.45 $12,236 - $23,030
1,400 New
1,400 $23,000
Q1 2022

May 16, 2022

SELL
$5.9 - $9.45 $544,570 - $872,234
-92,300 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$8.69 - $12.48 $802,087 - $1.15 Million
92,300 New
92,300 $845,000

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $404M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.